Related Experiment Video
Updated: Jun 1, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Alpha-1 antitrypsin is a potential biomarker for hepatitis B
Xu-fei Tan1, Shan-shan Wu, Shu-ping Li
1State Key Laboratory of Infectious Disease Diagnosis and Treatment, First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.
Researchers identified alpha-1 antitrypsin (AAT) as a potential biomarker for hepatitis B. Elevated AAT levels in serum correlate with severe chronic hepatitis and hepatic carcinoma, aiding in diagnosis.
Area of Science:
- Biochemistry
- Hepatology
- Proteomics
Background:
- Protein function is critical in disease progression, necessitating systematic identification of disease-specific proteins.
- While many proteins affect hepatitis, a systematic screen for hepatitis B virus (HBV)-induced hepatitis is lacking, hindering comprehensive understanding.
Purpose of the Study:
- To identify key proteins involved in the progression of HBV infection from mild to severe stages.
- To investigate the role of specific proteins in the pathogenesis of hepatitis B.
Main Methods:
- Employed a combined strategy of two-dimensional electrophoresis (2-DE) and peptide mass fingerprinting (PMF) for protein screening.
- Utilized tissue microarray techniques to determine the localization of identified functional proteins.
- Performed MS/MS identification and immunoblotting with specific antibodies for validation.
Main Results:
- Alpha-1 antitrypsin (AAT) expression was significantly elevated in serum from patients with severe chronic hepatitis and hepatic carcinoma.
- AAT showed highest expression in normal tissues and cells, but lowest in cancerous and severe hepatitis tissues, indicating secretion into serum.
- Confirmed high AAT expression in serum of patients with hepatic carcinoma and severe chronic hepatitis.
Conclusions:
- Alpha-1 antitrypsin (AAT) shows potential as a diagnostic biomarker for hepatitis B.
- The differential expression and secretion of AAT suggest its involvement in hepatitis B progression.
- Further research into AAT's role could improve hepatitis B diagnosis and management.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Viral Hepatitis I: Introduction

